Hot Features
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company’s lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expre... Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company’s lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.5 | -6.00240096038 | 8.33 | 9.4734 | 7.83 | 131272 | 8.70282064 | CS |
| 4 | -0.68 | -7.99059929495 | 8.51 | 9.4734 | 7.09 | 118040 | 8.21345728 | CS |
| 12 | 0.33 | 4.4 | 7.5 | 9.4734 | 6.01 | 124114 | 7.55423357 | CS |
| 26 | 7.2697 | 1297.46564341 | 0.5603 | 9.4734 | 0.4601 | 547324 | 2.16118307 | CS |
| 52 | 7.08 | 944 | 0.75 | 9.4734 | 0.4601 | 850060 | 1.2177555 | CS |
| 156 | 2.49 | 46.6292134831 | 5.34 | 9.4734 | 0.4471 | 865721 | 1.62355984 | CS |
| 260 | -4.48 | -36.3931762794 | 12.31 | 21.87 | 0.4471 | 734389 | 4.88969928 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.